KCM
Kingdon Capital Management’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-75,700
| Closed | -$14M | – | 66 |
|
2024
Q4 | $14M | Buy |
75,700
+1,600
| +2% | +$295K | 1.99% | 14 |
|
2024
Q3 | $14.6M | Buy |
74,100
+4,300
| +6% | +$847K | 1.62% | 14 |
|
2024
Q2 | $14.4M | Buy |
+69,800
| New | +$14.4M | 1.55% | 14 |
|
2022
Q3 | – | Sell |
-38,365
| Closed | -$8.21M | – | 56 |
|
2022
Q2 | $8.21M | Sell |
38,365
-11,835
| -24% | -$2.53M | 1.39% | 16 |
|
2022
Q1 | $14.3M | Buy |
+50,200
| New | +$14.3M | 1.49% | 14 |
|